Ads
related to: breast cancer drug- Overall Survival Results
See Updated Overall Survival Data
For This Treatment Option
- Dosing & Administration
Read More About Dosing
And How To Prescribe
- Patient Support
View The The Service Request Form
To Gain Access To Support Programs
- Financial Resources
Learn About The Available Access
Programs For Your Patients
- Official Video Library
See A Medical Expert Discuss
Overall Survival Data For mBC
- Safety Profile
View The Full Safety Profile And
See Side Effects For This Option
- Overall Survival Results
Search results
Breast cancer ‘immunity’ for survivors could be achieved by killing ‘undruggable’ cells
Daily Telegraph· 7 days agoAround 10 per cent of survivors will suffer a relapse, but this increases to 40 per cent among...
... for a CDK2 Inhibitor in Combination with an Approved CDK4/6 Inhibitor in HR+/HER2- Breast Cancer...
FOX 4 Kansas City· 6 days agoThe data, which mark the first promising clinical results for a CDK2 inhibitor in combination with an approved CDK4/6 inhibitor, will be presented at the 2024 American Society of Clinical Oncology ...
What to know about the blood test to detect colon cancer recommended by an FDA panel
ABC News· 5 days agoA blood test to screen for colorectal cancer is one step closer to receiving approval from the U.S....
Gilead and Cartography enter deal to develop cancer therapies
Pharmaceutical Technology via Yahoo Finance· 21 hours agoCartography looks forward to working with Gilead and leveraging the team’s expertise in oncology and...
Puma Biotechnology (PBYI) Falls 38% in 3 Months: Here's Why
Zacks via Yahoo Finance· 6 days agoSales of Puma Biotechnology's (PBYI) sole marketed drug, Nerlynx, have been declining in recent...
BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTSâ„¢ First in Human Study
Digital Journal· 2 days ago“We are extremely excited about partnering with BeiGene on this novel immunotherapy approach with planned expansion to prostate...immunotherapy has shown survival and clinical benefit in patients ...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 7 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 15 hours agoSixteen Researchers from Florida Cancer Specialists & Research Institute Share Cancer Care Discoveries at 2024 ASCO® Annual Meeting PR Newswire FORT MYERS ...
Gilead pays $20M to join Cartography's next-gen cancer medicine expedition
FierceBiotech· 2 days agoGilead Sciences is drawing up $20 million cash to partner with Cartography Biosciences and navigate ...
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 3 days agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
Ads
related to: breast cancer drug